Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petrou

Showing results (21-30 of 2,091) with videos related to

Pageof 210
Sort By:
Journal of Medical Economics|May 25, 2024
The efficiency of TAVI in intermediate and low-risk Japanese patientsPanagiotis Petrou
Value in Health Regional Issues|November 25, 2016
Global Budget for Cyprus' National Health System: The Promised Land or a No Man's Land?Panagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|March 4, 2014
The power of r - pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?Panagiotis Petrou
Journal of Medical Economics|February 12, 2024
Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture <i>fat and happy</i> stand true?Panagiotis Petrou
Hemoglobin|December 17, 2009
Preimplantation genetic diagnosisMary Petrou
International Journal of Cardiology. Heart & Vasculature|February 7, 2023
The economics of TAVI: A systematic reviewPanagiotis Petrou
BJOG : an International Journal of Obstetrics and Gynaecology|May 24, 2003
Economic consequences of preterm birth and low birthweightStavros Petrou
Value in Health Regional Issues|November 16, 2021
A Systematic Review of the Economic Evaluations of Belimumab in Systemic Lupus ErythematosusPanagiotis Petrou
Health Policy (Amsterdam, Netherlands)|January 31, 2021
The 2019 introduction of the new National Healthcare System in CyprusPanagiotis Petrou
Journal of Medical Economics|February 5, 2021
Budget impact analysis: can we afford the added value?Panagiotis Petrou
Pageof 210

Showing results (21-30 of 2,091) with videos related to

Sort By:
Pageof 210
Journal of Medical Economics|May 25, 2024
The efficiency of TAVI in intermediate and low-risk Japanese patientsPanagiotis Petrou
Value in Health Regional Issues|November 25, 2016
Global Budget for Cyprus' National Health System: The Promised Land or a No Man's Land?Panagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|March 4, 2014
The power of r - pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?Panagiotis Petrou
Journal of Medical Economics|February 12, 2024
Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture <i>fat and happy</i> stand true?Panagiotis Petrou
Hemoglobin|December 17, 2009
Preimplantation genetic diagnosisMary Petrou
International Journal of Cardiology. Heart & Vasculature|February 7, 2023
The economics of TAVI: A systematic reviewPanagiotis Petrou
BJOG : an International Journal of Obstetrics and Gynaecology|May 24, 2003
Economic consequences of preterm birth and low birthweightStavros Petrou
Value in Health Regional Issues|November 16, 2021
A Systematic Review of the Economic Evaluations of Belimumab in Systemic Lupus ErythematosusPanagiotis Petrou
Health Policy (Amsterdam, Netherlands)|January 31, 2021
The 2019 introduction of the new National Healthcare System in CyprusPanagiotis Petrou
Journal of Medical Economics|February 5, 2021
Budget impact analysis: can we afford the added value?Panagiotis Petrou
Pageof 210